Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

HSA Approval

NUFILONG SOLUTION FOR INJECTION IN A PRE-FILLED SYRINGE 6MG/0.6ML

Approval Number

SIN16393P

Drug Name

NUFILONG SOLUTION FOR INJECTION IN A PRE-FILLED SYRINGE 6MG/0.6ML

Product Name

NUFILONG SOLUTION FOR INJECTION IN A PRE-FILLED SYRINGE 6MG/0.6ML

Approval Date

December 8, 2021

Registrant

PHARMA TO MARKET PTE. LTD.

Regulatory Information

Registrant

PHARMA TO MARKET PTE. LTD.

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

INJECTION, SOLUTION

Route of Administration

SUBCUTANEOUS

Medical Information

ATC Code

L03AA13

ATC Item Name

pegfilgrastim

Manufacturer Information

Pharmaceutical Manufacturer

PHARMA TO MARKET PTE. LTD.

Manufacturers

Biocon Biologics India Limited

Active Ingredients

Ingredient Name

Pegfilgrastim

Strength

6mg/syringe

Drug MonographPegfilgrastim

Documents

Package Inserts

1.4.3 NUFILONG LEAFLET SINGAPORE_NEW_revised Nov 2021.pdf

Approved: December 8, 2021

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

NUFILONG SOLUTION FOR INJECTION IN A PRE-FILLED SYRINGE 6MG/0.6ML - HSA Approval | MedPath